These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15930079)

  • 21. Carcinoid tumor, selective serotonin reuptake inhibitors, and diarrhea.
    Simbera Z; Balon R
    Psychosomatics; 2005; 46(1):88-9. PubMed ID: 15765829
    [No Abstract]   [Full Text] [Related]  

  • 22. [Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
    Bailly D
    Presse Med; 2006 Oct; 35(10 Pt 2):1507-15. PubMed ID: 17028514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cutaneous adverse effects during selective serotonin reuptake inhibitors therapy: 2 cases].
    Richard MA; Fiszenson F; Jreissati M; Jean Pastor MJ; Grob JJ
    Ann Dermatol Venereol; 2001; 128(6-7):759-61. PubMed ID: 11460042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluvoxamine and sleep disturbances in posttraumatic stress disorder.
    Neylan TC; Metzler TJ; Schoenfeld FB; Weiss DS; Lenoci M; Best SR; Lipsey TL; Marmar CR
    J Trauma Stress; 2001 Jul; 14(3):461-7. PubMed ID: 11534878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serotonin-selective reuptake inhibitor-induced enuresis in three pediatric cases.
    Hergüner S; Kilinçaslan A; Görker I; Tüzün U
    J Child Adolesc Psychopharmacol; 2007 Jun; 17(3):367-9. PubMed ID: 17630870
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predicting value of tryptophan/large neutral amino acids ratio on selective serotonin reuptake inhibitors.
    Lucini V; Lucca A; Catalano M; Smeraldi E
    Adv Exp Med Biol; 1996; 398():559. PubMed ID: 8906324
    [No Abstract]   [Full Text] [Related]  

  • 27. Antisocial ideation and activities precipitated by the administration of SSRIs.
    Glancy GD
    Can J Psychiatry; 1993 Dec; 38(10):695. PubMed ID: 8313312
    [No Abstract]   [Full Text] [Related]  

  • 28. [Citalopram].
    El-Armouche A; Zolk O; Eschenhagen T
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2253-6. PubMed ID: 14574639
    [No Abstract]   [Full Text] [Related]  

  • 29. Citalopram and fluvoxamine in Tourette's disorder.
    Bajo S; Battaglia M; Pegna C; Bellodi L
    J Am Acad Child Adolesc Psychiatry; 1999 Mar; 38(3):230-1. PubMed ID: 10087681
    [No Abstract]   [Full Text] [Related]  

  • 30. Hypomania induced by escitalopram: 2 case reports.
    Sharma RC
    Psychopharmacol Bull; 2009; 42(2):89-91. PubMed ID: 19629025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anxious depression and response to treatment.
    Nelson JC
    Am J Psychiatry; 2008 Mar; 165(3):297-9. PubMed ID: 18316424
    [No Abstract]   [Full Text] [Related]  

  • 32. Torsade de pointes induced by citalopram and amiodarone.
    Fayssoil A; Issi J; Guerbaa M; Raynaud JC; Heroguelle V
    Ann Cardiol Angeiol (Paris); 2011 Jun; 60(3):165-8. PubMed ID: 21295285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variation in the risk of suicide attempts and completed suicides by antidepressant agent in adults: a propensity score-adjusted analysis of 9 years' data.
    Schneeweiss S; Patrick AR; Solomon DH; Mehta J; Dormuth C; Miller M; Lee JC; Wang PS
    Arch Gen Psychiatry; 2010 May; 67(5):497-506. PubMed ID: 20439831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Attention to side effects enhances medical adherence.
    Vinberg M
    Acta Psychiatr Scand; 2007 Jan; 115(1):82. PubMed ID: 17201871
    [No Abstract]   [Full Text] [Related]  

  • 35. Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
    Maina G; Albert U; Salvi V; Bogetto F
    J Clin Psychiatry; 2004 Oct; 65(10):1365-71. PubMed ID: 15491240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quetiapine-induced weight gain and escitalopram.
    Holzer L; Paiva G; Halfon O
    Am J Psychiatry; 2005 Jan; 162(1):192-3. PubMed ID: 15625223
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
    Schneeweiss S; Patrick AR; Solomon DH; Dormuth CR; Miller M; Mehta J; Lee JC; Wang PS
    Pediatrics; 2010 May; 125(5):876-88. PubMed ID: 20385637
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluvoxamine. A review of its safety profile in world-wide studies.
    Wagner W; Zaborny BA; Gray TE
    Int Clin Psychopharmacol; 1994; 9(4):223-7. PubMed ID: 7868844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Withdrawal symptoms in connection with the use of selective serotonin reuptake inhibitors (SSRI)].
    Gram LF
    Ugeskr Laeger; 1998 Dec; 160(50):7291-3. PubMed ID: 9859737
    [No Abstract]   [Full Text] [Related]  

  • 40. Complex movement disorder associated with fluvoxamine.
    Bronner IM; Vanneste JA
    Mov Disord; 1998 Sep; 13(5):848-50. PubMed ID: 9756160
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.